Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.

Choong, Nicholas W

Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Jan 2008 - 59-67 p. digital

Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1556-1380

10.1097/JTO.0b013e31815e8566 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--administration & dosage
Antineoplastic Agents, Phytogenic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols
Camptothecin--administration & dosage
Carboplatin--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Combined Modality Therapy
Dose-Response Relationship, Drug
Female
Humans
Irinotecan
Lung Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Staging
Paclitaxel--administration & dosage
Survival Analysis